First patients to test new cancer drug in global trial
NCT ID NCT07230977
Summary
This is the first time a new drug called GenSci139 is being tested in people. The study aims to find a safe dose and see how the body processes the drug in patients with advanced solid tumors that have spread or cannot be removed by surgery. Researchers will also look for early signs that the drug can help shrink or control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shandong First Medical University Affiliated Cancer Hospital
RECRUITINGJinan, Shandong, 250117, China
Conditions
Explore the condition pages connected to this study.